about
Cytomegalovirus disease in renal transplant recipients: a single-center experienceGraft Function and Intermediate-Term Outcomes of Kidney Transplants Improved in the Last Decade: Analysis of the United States Kidney Transplant Database.Impact of prophylactic versus preemptive valganciclovir on long-term renal allograft outcomes.Recipient-related risk factors for graft failure and death in elderly kidney transplant recipients.The DRY box and C-terminal domain of the human cytomegalovirus US27 gene product play a role in promoting cell growth and survivalHerpesvirus infections in organ transplant recipientsActive cytomegalovirus infection in patients with septic shock.Evaluation of the IMMULITE® 2000 CMV IgM assay.Incidence of CMV-HCV coinfection in renal transplant recipient.The role of the cytomegalovirus antigenemia assay in the detection and prevention of cytomegalovirus syndrome and disease in solid organ transplant recipients: A review of the British Columbia experience.Cholestasis, ascites and pancytopenia in an immunocompetent adult with severe cytomegalovirus hepatitis.Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease.Cytomegalovirus disease in African-American kidney transplant patientsClinical significance of quantitative and qualitative detection of BK and JC virus in blood and urine of renal transplantation recipients.Viral infection after renal transplantation: surveillance and management.Cytomegalovirus infection in renal transplantation: clinical aspects, management and the perspectives.The Association Between Viral Infections and Co-stimulatory Gene Polymorphisms in Kidney Transplant Outcomes.Allograft rejection-related gene expression in the endothelial cells of renal transplantation recipients after cytomegalovirus infection.Value of anti-infective chemoprophylaxis in primary systemic vasculitis: what is the evidence?Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients.Profile of infections in renal transplant recipients from India.Stimulation of B lymphocytes by cmvIL-10 but not LAcmvIL-10Cytomegalovirus infection and unusual early graft dysfunction in a renal transplant recipient.Monitoring of cytomegalovirus infection in solid-organ transplant recipients by an ultrasensitive plasma PCR assay.Correlation between CMV Infection and Post-transplantation New-onset Diabetes Mellitus.Risk factors for cytomegalovirus disease in seropositive renal transplant recipients; a single-center case-controlled study.Does CMV infection impact the virulence of Enterococcus faecalis?Answer to January 2014 Photo Quiz.Viral infection in renal transplant recipients.High frequency of valganciclovir underdosing for cytomegalovirus prophylaxis after renal transplantationSodium Polystyrene Sulfonate and Cytomegalovirus-Associated Hemorrhagic Duodenitis: More than Meets the Eye
P2860
Q33410118-CD488D4E-DB60-4CE7-A9DF-16D03CAEFAFEQ33779071-CC1B87C8-CD87-4505-8944-99C6616A9621Q34077023-B108B890-B223-4738-AA09-004244950E96Q34498112-57996A2E-D9A1-4CCC-A683-C6C147A95234Q34542503-41C1216A-346C-463A-A724-D36694C16765Q34579836-32171C0C-1F47-4B57-8EAE-202F45D3BE9BQ35792205-5A1AFA56-E439-4EF0-AFAA-B47222486B81Q35866312-E6C640D8-4D88-48DD-83DF-B15B4B5D1D91Q35919439-C9F1D005-3A06-47E1-A92A-F2B4D451C4F6Q36170937-6126CCB4-7CBC-48D0-A374-06F3E3EF7561Q36290448-AA61E051-3555-44D2-B2E7-EC1FE4B5A3DEQ36399914-2A8652C7-0AE2-43BD-B8D3-3AE6589E8755Q36614140-0938C0EC-871F-413F-BA52-61884A354A6BQ36876460-BEE33163-9EB9-48AA-BF5A-F3FCF26B108EQ37097708-6B41FFCF-44E1-455E-BE7D-CEF06389D06FQ37098580-3B8A6EBE-EC76-4AC8-9FC1-0885A30CAB90Q37361121-2F822966-DF4A-41DA-83E9-EC26161662F5Q37411026-E16D6C6C-BFC5-4549-91F9-238D4A21B714Q37453850-AAC009A4-8755-4081-81B8-A9131F522E76Q37612990-F54DBE76-95B1-4381-9273-545DDD44C477Q37623223-A41CA125-9497-4AE4-9C83-715C0B291F9EQ38272620-30B5BD36-7B76-4C12-B284-719AF085FF3EQ39681707-051091DA-7F80-4D0F-A11E-C2E0F6C0F889Q39848377-1B3DE0E9-0F40-412D-998D-E176CEB94363Q40512277-ABBEE3F0-67DF-4EE1-B400-FD048D918E9CQ41892541-BFF46A76-E79C-44C5-B6C4-554BD270E196Q42724573-430D7469-9997-45F8-ABC9-33A5664146CAQ45751876-A5C248A1-8D44-4FB1-9AE0-13D41B1D608FQ51594265-84E0FE97-743B-4E64-B5D9-8C8B276B2165Q56963171-E29971D6-92D4-4916-8E52-319647164328Q58801589-C17429FD-B85C-42D1-B463-5D5D829D4BFF
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Cytomegalovirus in renal transplantation.
@ast
Cytomegalovirus in renal transplantation.
@en
Cytomegalovirus in renal transplantation.
@nl
type
label
Cytomegalovirus in renal transplantation.
@ast
Cytomegalovirus in renal transplantation.
@en
Cytomegalovirus in renal transplantation.
@nl
prefLabel
Cytomegalovirus in renal transplantation.
@ast
Cytomegalovirus in renal transplantation.
@en
Cytomegalovirus in renal transplantation.
@nl
P1476
Cytomegalovirus in renal transplantation
@en
P2093
Brennan DC
P304
P577
2001-04-01T00:00:00Z